Bioactive Compounds in Cymbopogon ambiguus and Their Anti-Platelet Activity
Author Information
Author(s): I. Darren Grice, Kelly L. Rogers, Lyn R. Griffiths
Primary Institution: Griffith University
Hypothesis
The study aims to identify bioactive compounds from Cymbopogon ambiguus that explain its anti-headache activity.
Conclusion
The study found that eugenol and elemicin from Cymbopogon ambiguus exhibit significant anti-platelet activity, supporting its traditional use for headache treatment.
Supporting Evidence
- Eugenol was found to have an IC50 value of 46.6 μM, comparable to aspirin's IC50 of 46.1 μM.
- Elemicin exhibited a much higher IC50 value of 1729.8 μM, indicating lower potency than eugenol.
- The study provides evidence supporting the traditional use of Cymbopogon ambiguus for headache treatment.
Takeaway
Researchers found that a plant called Cymbopogon ambiguus has special ingredients that can help stop headaches by affecting how platelets in our blood work.
Methodology
The study involved extracting compounds from Cymbopogon ambiguus and testing their effects on human platelet aggregation and serotonin release.
Limitations
The study primarily focused on a limited number of compounds and their effects, which may not represent the full range of bioactive substances in the plant.
Participant Demographics
Healthy human volunteers aged 20 to 35, not taking aspirin or other drugs likely to interfere with platelet function.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website